课题基金 / 基金详情

Investigation for the methods of enhanced tumor vaccination using apoptosis-resistant dendritic cells manipulated by transfection of small-interfering RNAs responsible for the apoptosis of dendritic cells

Investigation for the methods of enhanced tumor vaccination using apoptosis-resistant dendritic cells manipulated by transfection of small-interfering RNAs responsible for the apoptosis of dendritic cells
研究通过转染负责树突状细胞凋亡的小干扰RNA来操纵抗凋亡树突状细胞增强肿瘤疫苗接种的方法
批准号:
17591155
负责人:
NAKAGAWA Satoshi
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

NAKAGAWA Satoshi的其他基金

相似基金

相关文献

中文摘要
翻译
首先,我们分析了人单核细胞来源的树突状细胞(MoDC)的自然凋亡过程中的生存力和半胱氨酸天冬氨酸蛋白酶2,3,7和8的表达,这些细胞通过IL-1 β,IL-6,TNF α和PGE 2刺激而成熟。MoDC在刺激2d后存活率大于90%,3和4d后降至60-70%,5d后降至50%。凋亡的MoDC百分比在1至4天后持续低于10%,但在6至8天后下降至70-80%。至于共刺激分子如CD 86和HLA-DR抗原的表达,两者在2天后上调,但在6天或更长时间后,发现MoDC的2个亚群:一个保持这两种分子的高表达,另一个减少这些分子。在上述的caspase中,只有caspase-2在MoDC的凋亡过程中表达上调。首先,我们尝试用脂质体转染法转染GAPDH siRNA,以寻找最佳的转染试剂。我们使用了TransIT-TKO[○!R](Mirus),siPortNeoFX[○!R]和siPortAmine[○!R](Ambion),Dharmafect1,2,3,4[○!R](Dharmacon)和Lipofectamine 2000 [○!R](Invitrogen)。在这些试剂中,Lipofectamine 2000 [○!R]表现出最好的结果,最大抑制44%。我们还尝试了使用Nucleofector^<TM>II(Amaxa)的电泳方法,导致最大70%的抑制。我们现在正试图将caspase 2-siRNA转染到MoDC中,并检查caspase 2-siRNA是否可以延长成熟MoDC的活力。
英文摘要
First we analyzed the viability and the expression of caspases 2, 3, 7 and 8 during the natural apoptotic course of human monocyte-derived dendritic cells (MoDC) which were matured by stimulation with IL-1beta, IL-6, TNFalpha, and PGE2. The viability of MoDC was more than 90% after 2 days of stimulation and decreased to 60-70% after 3 and 4 days, and finally fell into 50% after 5 days. The percentage of apoptotic MoDC was sustained less than 10% after 1 to 4 days, but decreased into 70-80% after 6 to 8 days. As for the expression of the costimulatory molecules such as CD86 and HLA-DR antigen, both were upregulated after 2 days but after 6 days and longer, 2 subpopulations of MoDC were found : one keeping high expression of both molecules, the other reducing these molecules. Among the caspases described above, only caspase-2 was found to be upregulated during the course of the apoptotic process of MoDC.Next we performed to transfect small interfering RNA (siRNA) into human MoDC. First we tried to transfect GAPDH siRNA by lipofection methods to search the best transfection reagents. We used TransIT-TKO【○!R】(Mirus), siPortNeoFX【○!R】 and siPortAmine【○!R】 (Ambion), Dharmafect1, 2, 3, 4【○!R】 (Dharmacon), and Lipofectamine2000【○!R】 (Invitrogen). Among these reagents, Lipofectamine2000【○!R】 performed the best results, maximally 44% of the inhibition. We also tried electrophoration methods using Nucleofector^<TM> II (Amaxa) resulting in maximally 70% of inhibition. We are now trying to transfect caspase2-siRNA into MoDC and examining whether caspase2-siRNA can prolong the viability of mature MoDC.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Studies of Twenty-four-volume late editions of "Sanguozhi-Yanyi"
Transnational migration into Thailand
  • 批准号:
    24652161
  • 项目类别:
    Grant-in-Aid for Challenging Exploratory Research
  • 资助金额:
    $2.0万
  • 财政年份:
    2012
  • 负责人:
    NAKAGAWA Satoshi
  • 依托单位:
Syntactic Analysis of the Development and Derivation of Double Copular Constructions
  • 批准号:
    24720226
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
  • 资助金额:
    $0.5万
  • 财政年份:
    2012
  • 负责人:
    NAKAGAWA Satoshi
  • 依托单位:
Molecular understanding of host-symbiont interaction in deep-sea hydrothermal fields.
国内基金
海外基金
Epac1/2通过蛋白酶体调控中性粒细胞NETosis和Apoptosis在急性肺损伤中的作用研究
  • 批准号:
    LBY21H010001
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2020
  • 负责人:
    郑绪阳
  • 依托单位:
去乙酰化酶SIRT1在前体mRNA可变剪切中的作用及其生理病理效应研究
  • 批准号:
    31970691
  • 项目类别:
    面上项目
  • 资助金额:
    58.0万元
  • 批准年份:
    2019
  • 负责人:
    张胜萍
  • 依托单位:
TM9SF4调控非小细胞肺癌细胞凋亡机制研究
  • 批准号:
    31900527
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    24.0万元
  • 批准年份:
    2019
  • 负责人:
    孙磊
  • 依托单位:
基于Apoptosis/Ferroptosis双重激活效应的天然产物AlbiziabiosideA的抗肿瘤作用机制研究及其结构改造
  • 批准号:
    81703335
  • 项目类别:
    青年科学基金项目
  • 资助金额:
    20.0万元
  • 批准年份:
    2017
  • 负责人:
    卫高菲
  • 依托单位: